Drug · DIN 02328313
TARO-RISPERIDONE
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 10, 2025; first marketed October 22, 2009.
- Drug Identification Number (DIN)
- 02328313
- Company (DIN owner)
- Sun Pharma Canada Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- July 10, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 23, 2021: NOC 27287Abbreviated New Drug Submission (ANDS) · Updated product monograph and labelling materials. Administrative: Manufacturer and Product Name Change
- October 4, 2011: NOC 12678Supplement to an Abbreviated New Drug Submission (SANDS) · Product Name Change
- June 30, 2009: NOC 10319Abbreviated New Drug Submission (ANDS)
Other DINs named TARO-RISPERIDONE
- DIN 02328305 · Dormant
- DIN 02328321 · Dormant
- DIN 02328348 · Dormant
- DIN 02328364 · Dormant
- DIN 02328372 · Dormant